• Facebook
  • Twitter
  • Youtube
  • Instagram
  • LinkedIn
  • Rss
  • Store
  • Donate
NCCS - National Coalition for Cancer Survivorship
  • About
    • Our Mission
    • Our History
    • The 1986 Club
    • Our Team
      • Policy Advisors
    • Employment
    • Partnerships
    • Financial Information
  • Policy
    • Quality Cancer Care
    • Access to Care
    • Health Equity
    • Redefining Functional Status (RFS)
    • 2022 State of Cancer Survivorship Survey
    • 2021 State of Cancer Survivorship Survey
    • 2020 State of Cancer Survivorship Survey
    • Cancer Care Planning and Communications Act (CCPCA)
  • Get Involved
    • What is Advocacy?
    • Cancer Policy and Advocacy Team (CPAT)
    • Survivorship Champions
    • Subscribe to NCCS Updates
    • Elevating Survivorship
    • Survivor Stories
    • Cancerversary
    • State-Based Cancer Advocacy
  • Resources
    • COVID-19 Resources for Cancer Survivors
    • Survivorship Checklist
    • Cancer Survival Toolbox
    • Telehealth
    • Publications
      • Talking With Your Doctor
      • Self Advocacy
      • Employment Rights
      • Remaining Hopeful
    • Cancer Convos Podcast
    • Taking Charge of Your Care
    • Care Planning for Cancer Survivors
    • Tools For Care Providers
    • Order Our Resources
  • News
  • Events
    • Ellen L. Stovall Award
      • 2022 Winners
      • Awardees
      • Sponsors
      • Committees
    • Cancer Policy Roundtable (CPR)
      • Fall 2022 CPR
      • Spring 2022 CPR
      • Fall 2021 CPR
      • Spring 2021 CPR
      • Fall 2020 CPR
      • Spring 2020 CPR
    • Cancer Policy and Advocacy Team (CPAT) Virtual Symposium 2022
    • 2022 State of Survivorship Survey Results
    • Webinars
  • Contact Us
  • Search
  • Menu Menu
  • 0Shopping Cart

Your generous year-end donation will be matched $1 for $1    DONATE

When Even the Best Advice Isn’t Good Enough

Guest Post by Dr. Don Dizon: When Even the Best Advice Isn’t Good Enough

February 20, 2015/in Cancer News, Cancer Policy Blog Care Coordination, Clinical Guidelines, Quality Cancer Care, Survivorship Care NCCS News /by actualize
Don S. Dizon, MD, FACP

Guest Post By
Don S. Dizon, MD, FACP

Every so often I see a patient who views cancer as a constant threat to be handled — it becomes so significant that it is as if she can never let her guard down. I always worry about this, partly because that singular focus on fighting cancer can sometimes detract one from other aspects of life, and those facets that give life meaning. Such was the case with Jane*.

Jane* has advanced ovarian cancer. At the time she was initially diagnosed, she was a very successful attorney — on her way to partner. She was married and they had been trying for their first kid. It was how she was diagnosed — a routine ultrasound of her pelvis delineated a mass in her ovary and labs showed a very elevated CA-125 level. Surgery followed and while she had a complete removal of tumor, the disease was far more advanced than imaging suggested. The whole thing happened so quickly — she had not even absorbed the fact she would never carry her own child as she began medical treatment. At each chemotherapy visit, I would no sooner walk in the room that Jane would inquire about her CA-125. She seemed so relieved when I told her it was normal, and honestly, I was ecstatic for her. By the time she entered follow-up, we fell into a routine. Instead of a “Hi, how are you doing”, I would enter the room and tell her, “Your CA-125 is still in the normal range.” She was always so relieved and happy to hear it. That is, until she relapsed.

Jane was devastated by her recurrence. She could not understand what had happened — what she had done “wrong”. “I stopped eating sugar, reduced saturated fats. I practiced yoga and religiously worked out. I cut back at work so I wouldn’t have more stress than I thought I could handle — heck, I even passed up my chance at partnership. But it still came back.” I assured her that she did not do anything wrong — that sometimes, for reasons we have yet to uncover, ovarian cancer recurs at a very high rate. I told her she was okay, that we could treat her, though the goal was no longer cure, but rather it was control.

Recurrence transformed her. She had a new sense of purpose — to stay alive. To her, it meant being “on top” of the cancer, to never yield the “upper hand”. We began pegylated liposomal doxorubicin, and I had counselled her not to be alarmed if her CA-125 went up before it started to fall. She tolerated it well and had no real side effects from treatment. But after two visits in which I told her, “your CA-125 went up a little bit”, she requested that we change treatment.

“Why would you want to change treatment now?”
“My CA-125 isn’t falling. If treatment worked, it would fall.”
“Remember how I told you that a rise in the CA-125 is expected? And besides, clinically, you have no signs or symptoms that you are progressing.”

We discussed this for a bit — me recommending at least one more dose of treatment and she asking for an entire new plan. Finally, I suggested we get a CT scan before we made a treatment decision, arguing that if it did not show disease progression then it meant treatment was working. However, she countered that it didn’t matter. “Even if it’s not growing yet, we know it’s going to.”

At this point, I took a step back to try to figure out what was motivating her request.

“Can I ask you, why would you want to change treatments so soon?”
“Because, I want to live,” she said. “And I don’t want to make another mistake. The next one might cost me my life.”

It dawned on me that no matter what I had said in the past, she did not really believe my line of “cancer as a chronic disease”. She was still afraid — very afraid. Afraid that her CA-125 would never fall, that her cancer would keep progressing, and afraid she would die. I would learn later from her husband that she had been recording each and every CA-125 since diagnosis, and how had taken to recording every symptom she experienced. She stayed up searching for new treatments, reading blogs and other women’s experiences with the disease. She had become obsessed with “beating” cancer.

Ultimately I convinced her to proceed with the CT scan. She wasn’t pleased that we had delayed a decision about staying on pegylated liposomal doxorubicin, but at the end of that visit, I felt she had understood the rationale and my approach.

DizonBlockThe next week I received a letter from Jane. She stated she was going to transfer her care. She thanked me for being her doctor these past years. “I just feel I won’t get the care I need to stay alive, “ she wrote. “We want to approach this cancer differently, and I’m sorry — but it’s my life at stake. I found a doctor that understands my view better and he recommended we change treatment.”

After that letter, it was my turn to ask, “What did I do wrong?” I could have changed her treatment as she had requested, without using a CT scan. I could have come off as less “academic” when discussing the evidence. It would’ve been easy for me to chalk up her decision to her own irrational conception of CA-125 and its meaning. But that would be wrong, because I had a direct hand in shaping how she perceived it. We had been following her CA-125 all along- every three weeks during her first treatment, then every three months while she was in remission. I shared in her joy when it reverted to a normal value and celebrated with her each time it was normal afterwards. Now that she recurred, it didn’t have the same importance — to me, but not to her. She had become “addicted” to CA-125, and I had a hand in that.

After Jane, I realized the context for this blood test needed to be made more clear — early on and frequently repeated. CA-125 should not and cannot be perceived as the sole measure of disease, and treatment based on a CA-125 is not a key to long-term survival.

I don’t know if I could have said anything differently to Jane to stop her from finding a new doctor, short of changing treatment as she requested. But approaching cancer requires a relationship built on trust and comfort — things that had apparently diminished with our last conversation. I knew then that she was right in finding a new doctor and ultimately, I wrote her back, wishing her well and that, despite the fact she had changed providers, I would always be available should she ever need me.

*The name and all patient details have been changed to protect her privacy.


Don S. Dizon, MD, FACP, is formerly an Associate Professor at The Warren Alpert Medical School of Brown University and is now affiliated with Harvard Medical School. He practices medical gynecologic oncology at the Massachusetts General Hospital (MGH) Cancer Center, where he also is Founder and Director of the Oncology Sexual Health Clinic. Dr. Dizon serves as Chair-Elect for ASCO’s Cancer Communications Committee. In addition to his regular column on ASCOconnection.org, which has been honored with APEX awards in 2013 and 2014, he is a blogger for MGH and Deputy Editor at UpToDate.
Follow Dr. Dizon on Twitter@drdonsdizon. The views & opinions expressed in any guest post featured on our site are those of the guest author and do not necessarily reflect the opinions & views of the National Coalition for Cancer Survivorship. Read our blog and comment policies here.

Tags: ASCO, cancer care, Cancer Survivorship, clinical guidelines, ePatient, Guest Post, quality, screening
Share this entry
  • Share on Facebook
  • Share on Twitter
  • Share on WhatsApp
  • Share on LinkedIn
https://canceradvocacy.org/wp-content/uploads/When-Even-the-Best-Advice-Isnt-Good-Enough.jpg 321 699 actualize https://canceradvocacy.org/wp-content/uploads/2020/06/NCCA-Logo.png actualize2015-02-20 11:19:512020-11-24 11:47:40Guest Post by Dr. Don Dizon: When Even the Best Advice Isn’t Good Enough

Latest News

NCCS Advocate Spotlight: Sharon Rivera Sanchez - Triple Negative Breast Cancer Survivor Finds Passion in Fitness and Advocacy

Sharon Rivera-Sanchez: Triple Negative Breast Cancer Survivor Finds Passion in Fitness and Advocacy

January 12, 2023
As a Triple Negative Breast Cancer survivor, Sharon turned her personal experience into a passion for advocacy and giving back to the community. When she received her diagnosis in May 2015, she remembers being in a state of shock and grief. She said, “You have to allow yourself time to breathe and grieve.”
Read more
https://canceradvocacy.org/wp-content/uploads/Advocate-Spotlight-Sharon-Rivera-Sanchez.jpg 600 1200 NCCS Staff https://canceradvocacy.org/wp-content/uploads/2020/06/NCCA-Logo.png NCCS Staff2023-01-12 15:24:442023-01-12 15:24:44Sharon Rivera-Sanchez: Triple Negative Breast Cancer Survivor Finds Passion in Fitness and Advocacy
Rep. Debbie Wasserman Schultz introduces Comprehensive Cancer Survivorship Act at December 14, 2022 press conference.

NCCS Celebrates Launch of Comprehensive Cancer Survivorship Act

December 14, 2022
Representative Debbie Wasserman Schultz (FL-23), a champion for cancer survivors and a survivor herself, held a press conference today…
Read more
https://canceradvocacy.org/wp-content/uploads/CCSA-Blog-Featured-Image-1200-×-600-px-1.png 600 1200 Kara Kenan https://canceradvocacy.org/wp-content/uploads/2020/06/NCCA-Logo.png Kara Kenan2022-12-14 16:03:462022-12-14 16:03:46NCCS Celebrates Launch of Comprehensive Cancer Survivorship Act
Alique Topalian, PhD, MPH Advocate Spotlight

Alique Topalian: Childhood Cancer and the Frightening Realities of the Survivorship Journey

December 7, 2022
Alique was first diagnosed with Acute Myeloid Leukemia (AML) at the age of four. Her mother, Michele, knew something was wrong because “the light in her eyes was gone”. After being told by doctors that there was nothing wrong, her family was relentless until new blood work uncovered blast cells.
Read more
https://canceradvocacy.org/wp-content/uploads/Alique-Topalian-Advocate-Spotlight.jpg 600 1200 NCCS Staff https://canceradvocacy.org/wp-content/uploads/2020/06/NCCA-Logo.png NCCS Staff2022-12-07 11:46:562022-12-07 11:48:28Alique Topalian: Childhood Cancer and the Frightening Realities of the Survivorship Journey

Take Action

Make An Impact

We are relentless in improving the quality of care and life after a cancer diagnosis. Your support makes all the difference right now.

Make a Gift »

Join CPAT

The NCCS Cancer Policy & Advocacy Team (CPAT) is a program for survivors and caregivers to learn about pressing policy issues that affect quality cancer care in order to be engaged as advocates in public policy around the needs of cancer survivors.

Share Your Story

NCCS represents the millions of Americans who share a common experience – the survivorship experience – living with, through and beyond a cancer diagnosis.

STAY CONNECTED

Together we can improve cancer care for survivors! Sign up to be the first to know about cancer policy issues and ways to take action

  • This field is for validation purposes and should be left unchanged.

  • About
    • Our Mission
    • Our History
    • The 1986 Club
    • Our Team
      • Policy Advisors
    • Employment
    • Partnerships
    • Financial Information
  • Policy
    • Quality Cancer Care
    • Access to Care
    • Health Equity
    • Redefining Functional Status (RFS)
    • 2022 State of Cancer Survivorship Survey
    • 2021 State of Cancer Survivorship Survey
    • 2020 State of Cancer Survivorship Survey
    • Cancer Care Planning and Communications Act (CCPCA)
  • Get Involved
    • What is Advocacy?
    • Cancer Policy and Advocacy Team (CPAT)
    • Survivorship Champions
    • Subscribe to NCCS Updates
    • Elevating Survivorship
    • Survivor Stories
    • Cancerversary
    • State-Based Cancer Advocacy
  • Resources
    • COVID-19 Resources for Cancer Survivors
    • Survivorship Checklist
    • Cancer Survival Toolbox
    • Telehealth
    • Publications
      • Talking With Your Doctor
      • Self Advocacy
      • Employment Rights
      • Remaining Hopeful
    • Cancer Convos Podcast
    • Taking Charge of Your Care
    • Care Planning for Cancer Survivors
    • Tools For Care Providers
    • Order Our Resources
  • News
  • Events
    • Ellen L. Stovall Award
      • 2022 Winners
      • Awardees
      • Sponsors
      • Committees
    • Cancer Policy Roundtable (CPR)
      • Fall 2022 CPR
      • Spring 2022 CPR
      • Fall 2021 CPR
      • Spring 2021 CPR
      • Fall 2020 CPR
      • Spring 2020 CPR
    • Cancer Policy and Advocacy Team (CPAT) Virtual Symposium 2022
    • 2022 State of Survivorship Survey Results
    • Webinars
  • Contact Us

National Coalition for Cancer Survivorship
8455 Colesville Road  |  Suite 930  |  Silver Spring, MD 20910
877-NCCS-YES  |  info@canceradvocacy.org
Privacy Policy  |  Terms and Conditions

Copyright © 1995-2023 by the National Coalition for Cancer Survivorship
National Coalition for Cancer Survivorship, NCCS, Cancer Survival Toolbox, and related Logos are registered in the United States as trademarks of the National Coalition for Cancer Survivorship.

WCOE: Elaine Schattner Reflects on David Carr and Survivorship, Oncology Payment... NCCS Starburst Thumbnail 20years Guest Post: Palliative Care in Oncology—We’ve Come a Long Way, Baby …But...
Scroll to top
Download the Survey Report

"*" indicates required fields

Fill out the form below, and we’ll send the survey report, detailed presentation, and infographic to your email.
Name*
I am a...*
Select any/all that apply.
Consent*
By downloading the survey materials, you will receive updates and information from NCCS via email, which you may unsubscribe from at any time. Your information will never be sold to any third parties.
This field is for validation purposes and should be left unchanged.

Get Updates From NCCS

Be the first to hear about cancer policy and survivorship issues! Subscribe and receive the biweekly NCCS Health Care Roundup, invites to webinars and events, and more.

  • This field is for validation purposes and should be left unchanged.

Connect With Us

Twitter     Facebook     Instagram     LinkedIn     YouTube

Harmar Brereton, MD

Founder
Northeast Regional Cancer Institute

 

“Perhaps one of the most impactful collaborations in Dr. Brereton’s extraordinary career remains his early work and long friendship with Ellen Stovall. Through him, and in turn through the thousands of lives he has touched, Ellen’s work continues, and her mission lives on.”

—Karen M. Saunders
President, Northeast Regional Cancer Institute